Immunovative Therapies
Manufacturing · Israel · 1-10 Employees
View Company Info for Free
Overview
Headquarters
PO Box 974, Shoham, Central District, 60...Phone Number
+972 39702090Website
www.immunovative.comRevenue
$7.5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Immunovative Therapies
Immunovative Therapies, Ltd. (ITL) is an Israeli biopharmaceutical company specializing in the development, manufacture and testing of next generation of immunotherapy products. ImmunoCare, Ltd. is a subsidiary of ITL that has been granted the exclusive worldwide marketing rights to CryoVax® in colorectal cancer. ITL was founded in May, 2004 with support from the Israel Office of the Chief Scientist and Hadassah-Hebrew University Medical Center. The Company has operations in Jerusalem, Phoenix, AZ USA and Thailand.Explore more
Immunovative Therapies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Immunovative Therapies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Immunovative Therapies recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Immunovative Therapies
Check if Immunovative Therapies has recently received funding, and reach out quickly before it becomes old news!
Click to see if Immunovative Therapies had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Immunovative Therapies, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Immunovative Therapies is spiking on competitors!
Funding: Get notified immidiatlly once Immunovative Therapies has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Immunovative Therapies launches new products
Recommended Actions
Reach out to Masked Content who joined Immunovative Therapies as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Immunovative Therapies is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Immunovative Therapies is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Immunovative Therapies.
Immunovative Therapies financials insights
Gather financial insights about Immunovative Therapies, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2012
Unspecified
$12M
Immunovative Therapies Tech Stack
A closer look at the technologies used by Immunovative Therapies
Immunovative Therapies News & Media
Immunovative Therapies to Present at Biotech Showcase™ 2019 in San Francisco
JERUSALEM, Dec. 10, 2018 /PRNewswire/ -- Immunovative Therapies, Ltd. today announced that it will present at Biotech Showcase™ 2019, to be held January 7–9 at the Hilton San Francisco Union Square. Dr. Michael Har-Noy, Founder and CEO, will present at Biotech Showcase™ as follows: Date:...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Immunovative Therapies
Sign Up For FreeTo access detailed company insights
Immunovative Therapies, Ltd. (ITL) is an Israeli biopharmaceutical company specializing in the development, manufacture and testing of next generation of immunotherapy products. ImmunoCare, Ltd. is a subsidiary of ITL that has been granted the exclusive worldwide marketing rights to CryoVax® in colorectal cancer. ITL was founded in May, 2004 with s... Read More
